D-0854-2016 Class III Ongoing
FDA drug recall D-0854-2016 was initiated by Hospira Inc. on Mar 23, 2016 and is designated Class III. Reason for recall: Failed pH Specifications: Confirmed high out of specification (OOS) results for pH. The recall status is ongoing. Affected quantity: 715,200 vials.
Recall details
- Product Type
- Drugs
- Report Date
- May 25, 2016
- Initiation Date
- Mar 23, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 715,200 vials
Product description
Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2168-02, barcode (01) 2 030409 216802 5.
Reason for recall
Failed pH Specifications: Confirmed high out of specification (OOS) results for pH.
Distribution pattern
Nationwide, Puerto Rico, United Arab Emirates, Israel, Kuwait, Bahrain, and Trinidad & Tobago
Code information
Lot #: 42-335-DK, Exp 1JUN2016; 48-128-DK, 48-129-DK, 48-261-DK, 48-262-DK, 48-351-DK, Exp 1DEC2016; 52-361-DK, Exp 1APR2017; note that the lot number may be followed by numbers from 01 to 99.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0854-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.